5Carom AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association[J]. Europace, 2012, 14(10): 1385-1413.
6Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral haemorrhage[J]. Neurology, 2007, 68(2): 116-121.
7Ono A, Fujita T. Low-intensity anticoagulation for stroke prevention in elderly patients with atrial fibrillation: eficacy and safety in actual clinical practice[J]. J Clin Neurosci, 2005, 12(8): 891-894.
8Edwin SB, Jennings DL, Kalus JS. An evaluation of the early pharmacodynamic response after simultaneous initiation of warfarin and amiodarone[J]. J Clin Pharmaeol, 2010, 50(6): 693-698.
9Flaker GC, Blackshear JL, McBride R, et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators[J]. J Am Coil Cardiol, 1992, 20(3): 527-532.
10Tang SS,Zhang JH, Tang BS, et al. Biochemical andhemostatic mechanism of a novel thrombin-like enzyme [J].Thromb Res,2009,124(5) :631-639.
